Apellis Pharmaceuticals (APLS) Insider Trading & Ownership → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free APLS Stock Alerts $40.37 -0.68 (-1.66%) (As of 06/7/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)13Amount OfInsider Selling(Last 12 Months)$42.62 M Get APLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APLS Insider Buying and Selling by Quarter Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Apellis Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/8/2024Pascal DeschateletsInsiderSell78,907$42.35$3,341,711.45 4/8/2024Pascal DeschateletsInsiderSell69,107$54.17$3,743,526.19 4/1/2024Timothy Eugene SullivanCFOSell4,000$58.66$234,640.00 3/19/2024A. Sinclair DunlopDirectorSell18,681$57.18$1,068,179.58 3/18/2024Mark Jeffrey DelongInsiderSell9,913$56.90$564,049.70 3/15/2024James George ChopasCAOSell184$56.46$10,388.64 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/13/2024Nur NicholsonInsiderSell11,220$57.56$645,823.20 3/1/2024Cedric FrancoisCEOSell250,000$64.11$16,027,500.00 3/1/2024Timothy Eugene SullivanCFOSell6,000$63.22$379,320.00 2/12/2024Adam J TownsendInsiderSell1,148$67.77$77,799.96 2/12/2024Cedric FrancoisCEOSell3,962$67.77$268,504.74 2/12/2024David O WatsonGeneral CounselSell781$67.77$52,928.37 2/12/2024Timothy Eugene SullivanCFOSell1,431$67.77$96,978.87 1/29/2024Cedric FrancoisCEOSell2,843$64.14$182,350.02 1/29/2024David O WatsonGeneral CounselSell906$64.14$58,110.84 1/29/2024Nur NicholsonInsiderSell835$64.14$53,556.90 1/22/2024Adam J TownsendInsiderSell3,413$65.00$221,845.00 1/22/2024Cedric FrancoisCEOSell13,431$65.00$873,015.00 1/22/2024David O WatsonGeneral CounselSell4,184$65.00$271,960.00 1/22/2024James George ChopasCAOSell1,061$65.00$68,965.00 1/22/2024Timothy Eugene SullivanCFOSell3,551$65.00$230,815.00 1/16/2024Cedric FrancoisCEOSell7,851$66.81$524,525.31 1/16/2024David O WatsonGeneral CounselSell4,240$66.81$283,274.40 1/16/2024James George ChopasCAOSell864$66.81$57,723.84 1/16/2024Jeffrey EiseleInsiderSell438$66.81$29,262.78 1/16/2024Timothy Eugene SullivanCFOSell2,235$66.81$149,320.35 1/4/2024Caroline BaumalInsiderSell2,751$60.05$165,197.55 12/26/2023Jeffrey EiseleInsiderSell68$57.86$3,934.48 12/19/2023David O WatsonGeneral CounselSell3,905$57.23$223,483.15 12/1/2023Lukas ScheiblerInsiderSell10,000$60.00$600,000.00 11/21/2023Cedric FrancoisCEOSell5,000$48.80$244,000.00 11/17/2023Alec MachielsDirectorSell1,250$47.74$59,675.00 11/8/2023Pascal DeschateletsInsiderSell12,000$47.27$567,240.00 10/23/2023James George ChopasCAOSell132$46.04$6,077.28 10/23/2023Mark Jeffrey DelongInsiderSell131$46.04$6,031.24 10/17/2023Alec MachielsDirectorSell1,250$48.50$60,625.00 10/9/2023Pascal DeschateletsInsiderSell12,000$40.38$484,560.00 9/18/2023Alec MachielsDirectorSell1,250$45.00$56,250.00 9/18/2023Nur NicholsonInsiderSell20,350$44.27$900,894.50 9/15/2023Alec MachielsDirectorSell1,250$45.34$56,675.00 Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy.9/8/2023Pascal DeschateletsInsiderSell12,000$42.87$514,440.00 9/1/2023Cedric FrancoisCEOSell150,000$41.75$6,262,500.00 8/31/2023James George ChopasCAOSell551$41.23$22,717.73 8/8/2023Pascal DeschateletsInsiderSell12,000$23.66$283,920.00 7/17/2023Alec MachielsDirectorSell1,250$64.79$80,987.50 7/10/2023Pascal DeschateletsInsiderSell12,000$84.55$1,014,600.00 7/3/2023David O WatsonGeneral CounselSell8,510$89.98$765,729.80 7/3/2023Timothy Eugene SullivanCFOSell6,779$89.97$609,906.63 6/20/2023Alec MachielsDirectorSell1,250$88.41$110,512.50 (Data available from 1/1/2013 forward) APLS Insider Trading Activity - Frequently Asked Questions Who is on Apellis Pharmaceuticals's Insider Roster? The list of insiders at Apellis Pharmaceuticals includes A. Sinclair Dunlop, Adam J Townsend, Alec Machiels, Caroline Baumal, Cedric Francois, David O Watson, Federico Grossi, James George Chopas, Jeffrey Eisele, Karen Lewis, Lukas Scheibler, Mark Jeffrey Delong, Morningside Venture Investment, Nicole D Perry, Nur Nicholson, Pascal Deschatelets, Timothy Eugene Sullivan, and Victoria L Brown. Learn more on insiders at APLS. What percentage of Apellis Pharmaceuticals stock is owned by insiders? 6.80% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings. Which Apellis Pharmaceuticals insiders have been selling company stock? The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($3,862,164.97), Adam J Townsend ($4,014,794.96), Alec Machiels ($1,195,537.50), Caroline Baumal ($165,197.55), Cedric Francois ($32,763,087.07), David O Watson ($2,100,586.56), Federico Grossi ($553,500.00), James George Chopas ($165,872.49), Jeffrey Eisele ($192,963.30), Karen Lewis ($957,418.90), Lukas Scheibler ($600,000.00), Mark Jeffrey Delong ($2,237,480.94), Nur Nicholson ($1,600,274.60), Pascal Deschatelets ($18,226,037.64), Timothy Eugene Sullivan ($7,897,356.05), and Victoria L Brown ($121,410.00). How much insider selling is happening at Apellis Pharmaceuticals? Insiders have sold a total of 1,285,365 Apellis Pharmaceuticals shares in the last 24 months for a total of $76,653,682.53 sold. More Insider Trading Tools from MarketBeat Related Companies: ALX Oncology Insider Transactions Omeros Insider Transactions Rigel Pharmaceuticals Insider Transactions Seres Therapeutics Insider Transactions Alnylam Pharmaceuticals Insider Transactions Teva Pharmaceutical Industries Insider Transactions Genmab A/S Insider Transactions Royalty Pharma Insider Transactions BeiGene Insider Transactions BioMarin Pharmaceutical Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Top 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying This page (NASDAQ:APLS) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apellis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.